ZHU Xinyi, ZHANG Wenxi, XI Zhaoqing, et al. Clinical Observation on Xuekeshu Extract(血可舒浸膏) in Treating Malignant Hematopathy Patients with Blood Stasis Syndrome[J]. Journal of Traditional Chinese Medicine2019, 60(14): 1213-1218.
ZHU Xinyi, ZHANG Wenxi, XI Zhaoqing, et al. Clinical Observation on Xuekeshu Extract(血可舒浸膏) in Treating Malignant Hematopathy Patients with Blood Stasis Syndrome[J]. Journal of Traditional Chinese Medicine2019, 60(14): 1213-1218.DOI: 10.13288/j.11-2166/r.2019.14.011.
Clinical Observation on Xuekeshu Extract(血可舒浸膏) in Treating Malignant Hematopathy Patients with Blood Stasis Syndrome
Objective To evaluate the clinical effects of Xuekeshu Extract( 血可舒浸膏) in the treatment of malignant hematopathy with blood stasis syndrome and study on its antithrombotic pathway from the aspect of thrombosis mechanism. Methods A total of 44 patients with malignant hematopathy and blood stasis syndrome were divided into a treatment group and a control group according to random number table
with 22 cases in each group. The control group was treated with routine therapy
and the treatment group was treated with oral administration of Xuekeshu Extract on the basis of the control group
5 g per time
three times per day. The clinical efficacy was evaluated by comparing the scores of blood stasis syndrome before and after treatment. The thrombotic events were observed. The hemodynamic indexes
coagulation function indicators
thrombelastogram( TEG) and thrombosis related indexes( thrombomodulin( TM)
plasma endothelin 1( ET-1)
protein C( PC)
tissue plasminogen activator( t-PA)
tissue plasminogen activator inhibitor( PAI)) were detected
and the safety was observed. Results After treatment
in comparison of the 2 groups:( 1) the curative effect and scores of traditional Chinese medicine syndromes of the treatment group were significantly better than those of the control group( P < 0. 05).( 2) The incidence of thrombosis
remission rate and new thrombosis rate were significantly improved
but there were no statistical difference( P >0. 05).( 3) The hemodynamic indexes showed that the whole blood high and medium shear rate viscosity
the red blood cell aggregation index
the reduced viscosity( low shear rate) and the K value of the ESR equation all decreased( P < 0. 05).( 4) TEG showed coagulation reaction time( R time) was prolonged and maximum amplitude( MA) value was decreased( P < 0. 05).( 5) There was no significant difference in TM
ET-1
PC
t-PA
PAI( P > 0. 05). However
compared with those before treatment
ET-1 decreased and PC increased( P < 0. 05).( 6)There was no significant difference in coagulation term and platelet count( P > 0. 05). No obvious adverse events occurred. Conclusion Xuekeshu Extract can obviously improve the symptoms of blood stasis in malignant hematopathy
and has certain effects on the prevention and treatment of thromboembolism. Xuekeshu Extract can reduce blood viscosity
and plasma endothelin
improve protein C content. It may play a role of antithrombus through the pathway of blood flow and vascular endothelium.
Effects of Yangxin Tongmai Formula (养心通脉方) on Methylation Key Genes and the PERK/ATF4/CHOP Signaling Pathway in Myocardial Tissue of Coronary Heart Disease Model Rats with Blood Stasis Syndrome
Construction of a Diagnostic Model for Coronary Heart Disease with Blood Stasis Syndrome Based on Objective Multi-Modal Data Fusion
Effect of Different Time Interventions of Yangxin Tongmai Formula (养心通脉方) on DNA Methylation in Rat Models of Premature Coronary Heart Disease with Blood Stasis Syndrome
Forty Cases of Mid-Stage Diabetes Kidney Disease Patients of Blood Stasis Syndrome Treated with Huayu Tongluo Formula (化瘀通络方) as an Adjunct Therapy: A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial
Association between Triglyceride-Glucose Index and Major Adverse Cardiovascular Events Risk in Coronary Heart Disease Patients with Blood Stasis Syndrome after Percutaneous Coronary Intervention
Related Author
ZHANG Chun
ZHANG Shumeng
MAO Yan
CHEN Xing
KUANG Huifang
YANG Yi
CHEN Lingli
LI Jie
Related Institution
Hunan University of Chinese Medicine
Beijing Key Laboratory of Traditional Chinese Medicine Basic Research on Prevention and Treatment of Major Diseases
Experimental Research Center,China Academy of Chinese Medical Sciences
School of Medicine,Hunan University of Chinese Medicine
School of Traditional Chinese Medicine,Hunan University of Chinese Medicine